Active Surveillance Prostate Cancer Video Chat, January 28th, 2026

Active Surveillance Prostate Cancer Video Chat, January 28th, 2026

Active Surveillance Prostate Cancer Video Chat, January 28th, 2026

 

 

AnCan is grateful to the following sponsors for making this recording possible: Bayer, Novartis, Johnson and Johnson, Myriad Genetics, Telix, and Blue Earth Diagnostics.

Active Surveillance (AS) for low-risk prostate cancer involves unique challenges compared to other treatments. This online support group is designed for men and their caregivers who are currently on or considering AS. We hold four meetings monthly, recording only the second and fourth sessions. Our discussions cover a wide range of topics, including anxiety management, biopsy experiences, and the decision-making process around continuing or discontinuing AS. Newcomers are given priority to share their experiences, so we encourage you to join us.

You can find out more about our 12 monthly prostate cancer meetings at https://ancan.org/prostate-cancer/. Sign up to receive a weekly Reminder/Newsletter for this Group or others at https://ancan.org/contact-us/.

Chat Log:

Eric- Atlanta 8:49 PM
2nd Opinions for Biopsies -Jonathan Epstein, MD Contact: jepstein@imppllc.com https://advanceduropathology.com -Ming Zhou, MD, PHD Now at Mount Sinai Health System in New York City. If you have questions for him, please contact him directly at Email: Ming.zhou@mountsinai.org -John Hopkins Pathology https://pathology.jhu.edu/patient-care/second-opinions

AnCan – Rick 8:50 PM
Recent article on finasteride/dutasteride and disease progression https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2822868?guestAccessKey=51fc10c5-3b12-4e00-903b-b8611dfbe9a5&utm_source=silverchair&utm_campaign=jama_network&utm_content=onc_weekly_highlights&utm_medium=email&adv=000002836268&mc_cid=c06ec53f6d&mc_eid=838454d636

Eric- Atlanta 9:18 PM
Latest April 2025 NCCN Guidelines for Early PCa: https://www.nccn.org/patients/guidelines/content/PDF/prostate-early-patient.pdf

AnCan – Rick 9:19 PM
Tx Dr. Dan – I recall there was something out there. Thanks

AnCan – Rick 9:22 PM
Early stage Guidelines https://www.nccn.org/patients/guidelines/content/PDF/prostate-early-patient.pdf

Hector 9:30 PM
https://ufhealth.org/news/2025/surprising-finding-could-pave-way-for-universal-cancer-vaccine

Hector 9:44 PM
This is now at the hypothetical level, no conclusive evidence yet: NPR: Could mRNA vaccines help fight cancer? https://www.npr.org/2022/06/05/1103178829/could-mrna-vaccines-help-fight-cancer

Active Surveillance Prostate Cancer Video Chat, January 14th, 2026

Active Surveillance Prostate Cancer Video Chat, January 14th, 2026

Active Surveillance Prostate Cancer Video Chat, January 14th, 2026

 

AnCan is grateful to the following sponsors for making this recording possible: Bayer, Novartis, Johnson and Johnson, Myriad Genetics, Telix, and Blue Earth Diagnostics.

Active Surveillance (AS) for low-risk prostate cancer involves unique challenges compared to other treatments. This online support group is designed for men and their caregivers who are currently on or considering AS. We hold four meetings monthly, recording only the second and fourth sessions. Our discussions cover a wide range of topics, including anxiety management, biopsy experiences, and the decision-making process around continuing or discontinuing AS. Newcomers are given priority to share their experiences, so we encourage you to join us.

You can find out more about our 12 monthly prostate cancer meetings at https://ancan.org/prostate-cancer/. Sign up to receive a weekly Reminder/Newsletter for this Group or others at https://ancan.org/contact-us/.

Chat Log:

Phil-Toronto 8:05 PM
Prostate Cancer Journal Club for Patients tomorrow at 9:00am ” can Micro U/S replace MRI for PCa Diagnosis Matt Cooperberg Laurence Klotz meded.ucsf.edu

Martin 8:13 PM
Brian, my email is martinuthe14@gmail.com. I would love to hear about your acqua ablation. Thx!

BJ 8:24 PM
Hi guys anyone have a link for the mentioned webinar tomorrow?

Phil-Toronto 8:25 PM
meded.ucsf.edu. If you google the link it should take you to the registration for the webinar tomorrow

Phil-Toronto 8:36 PM
aquablation vs. HOLEP https://www.perplexity.ai/search/80078b6b-bae2-4382-96d6-4035a1f29ba0

BJ 8:40 PM
Dan P: You mentioned a book at the beginning. if you can put the name of it on the chat. Ty

AnCan – Rick 8:50 PM
Dr. Sanjay Punnen https://sylvester-doctors.umiamihealth.org/provider/sanoj-punnen/525775

BJ 9:01 PM
Need to drop off. Thanks all for sharing so much.

AnCan – Rick 9:06 PM
Helfand webinar on AS on AnCan https://ancan.org/webinar-active-surveillance-beyond-with-dr-brian-helfand/

AnCan – Rick 9:13 PM
@RogerNorris…. PROSTATE, not prostrate.

Article Review – A Clear Guide to PCa Biomarkers

Article Review – A Clear Guide to PCa Biomarkers

Article Review – A Clear Guide to PCa Biomarkers

DISCLAIMER: AnCan does not endorse Superpower or any of its products.  All patients should discuss with their healthcare provider before using any of their products or any of the tests or advice in the article.

In another of the seemingly endless organizations offering premium health services, Superpower, founded in 2023, provides a fairly straightforward overview of the myriad tests and biomarkers available to Prostate Cancer patients (A Clear Guide to PCa Biomarkers).  Seasoned AnCaners may find little new in here, especially those that attend or review many of the recent seminars/webcasts, but newcomers or those needing a refresher may find it helpful for further research or equipping you to be your own best advocate. The article hits many of the main tests with which we are all familiar, as well as some of the urine biomarkers (PCA3, Select MDx, ExoDX), without specifically endorsing any of them.  It does touch on MRIs, but only multi-parametric, not bi-parametric MRIs, nor does it get into the trans-rectal versus trans-perineal debate. Be forewarned, there is information with which not everyone will agree (shocking, I know), but it is still a useful, albeit somewhat rudimentary tool.

Active Surveillance Prostate Cancer Video Chat, January 28th, 2026

Active Surveillance Prostate Cancer Video Chat, December 10th, 2025

Active Surveillance Prostate Cancer Video Chat, December 10th, 2025

 

 

AnCan is grateful to the following sponsors for making this recording possible: Bayer, Novartis, Johnson and Johnson, Myriad Genetics, Telix, and Blue Earth Diagnostics.

Active Surveillance (AS) for low-risk prostate cancer involves unique challenges compared to other treatments. This online support group is designed for men and their caregivers who are currently on or considering AS. We hold four meetings monthly, recording only the second and fourth sessions. Our discussions cover a wide range of topics, including anxiety management, biopsy experiences, and the decision-making process around continuing or discontinuing AS. Newcomers are given priority to share their experiences, so we encourage you to join us.

You can find out more about our 12 monthly prostate cancer meetings at https://ancan.org/prostate-cancer/. Sign up to receive a weekly Reminder/Newsletter for this Group or others at https://ancan.org/contact-us/.

 

Chat Log:

Hugh -Houston
2nd Opinions for Biopsies: -Jonathan Epstein, MD https://advanceduropathology.com -Ming Zhou, MD, PHD Now at Mount Sinai Health System in New York City. If you have questions for him, please contact him directly at Email: Ming.zhou@mountsinai.org) -John Hopkins Pathology https://pathology.jhu.edu/patient-care/second-opinions

Derek
👍

Eric- Atlanta
PROMISE/COLOR Genetic Study w/ANCAN affiliate link: https://www.prostatecancerpromise.org/?utm_campaign=ANCAN&utm_medium=link&utm_source=Webinar

Eric- Atlanta
Men Speaking Freely: https://ancan.org/series/men-speaking-freely/

Eric- Atlanta
Food & Nutrition: https://ancan.org/wp-content/uploads/2020/11/Prostate-Ca-AS_Nov-2020.pdf

Eric- Atlanta
2nd Opinions for MRIs: Botimage AI for MRIs: https://botimageai.com/prostatid/ ~$250, can also be used for biopsy targeting guidance -Second opinion of MRI from Johns Hopkins Images and Reports for Providers | Johns Hopkins Radiology (hopkinsmedicine.org) Email: eradiologycenter@jhmi.edu Phone: 443-287-7378 Fax: 443-769-1210 NIH 2nd Opinion MRI (no fees): Choyke, Peter (NIH/NCI) Radiologist pchoyke@mail.nih.gov -Accolade Radiology NY, PA https://accoladeradiology.com/mritap.html Radiology Check (Switzerland) https://radiologycheck.com/en

AnCan Bill
Got to drop gentlemen. Thanks for helping out Martin (and everyone else). Take care.

Martin Uthe
thank you. Bill!

Eric- Atlanta
Thank you Bill

AnCan – rick
Great advice, Dan G

Martin Uthe
Hi guys- have to run. Thank you so much for your time and support. Talk to you on Friday, Howard.

Howard Wolinsky
Dr. Eggener UCLA

Howard Wolinsky
FYI on perineural invasion–sounds scary–https://howardwolinsky.substack.com/p/part-ii-the-perineural-invaders?utm_source=publication-search

Joel _ Manassas, VA
Much appreciate all the helpful discussion. Best to all

Steve K
Thank you all!

 

 

Active Surveillance Prostate Cancer Video Chat, January 28th, 2026

Active Surveillance Prostate Cancer Video Chat, November 26th, 2025

Active Surveillance Prostate Cancer Video Chat, November 26th, 2025

 

 

AnCan is grateful to the following sponsors for making this recording possible: Bayer, Novartis, Johnson and Johnson, Myriad Genetics, Telix, and Blue Earth Diagnostics. 

Active Surveillance (AS) for low-risk prostate cancer involves unique challenges compared to other treatments. This online support group is designed for men and their caregivers who are currently on or considering AS. We hold four meetings monthly, recording only the second and fourth sessions. Our discussions cover a wide range of topics, including anxiety management, biopsy experiences, and the decision-making process around continuing or discontinuing AS. Newcomers are given priority to share their experiences, so we encourage you to join us.

You can find out more about our 12 monthly prostate cancer meetings at https://ancan.org/prostate-cancer/. Sign up to receive a weekly Reminder/Newsletter for this Group or others at https://ancan.org/contact-us/.

 

Chat Log:

Chris L. (Windsor, CA)
Gut microbiome & phytochemical rich diet: YouTube: https://www.youtube.com/watch?v=0vR0QL3oR2k

Chris L. (Windsor, CA)
Asco highlights: https://www.urotoday.com/conference-highlights/asco-gu-2025/asco-gu-2025-prostate-cancer/158203-asco-gu-2025-gut-health-and-prostate-cancer-the-influence-of-a-specific-phytochemical-rich-food-capsule-plus-or-minus-a-probiotic-prebiotic-blend-on-symptoms-and-progression-a-randomised-double-blind-placebo-controlled-trial.html

Eric- Atlanta
https://howardwolinsky.substack.com/p/breaking-transperineal-biopsies-find?utm_source=publication-search

Bill Harris (Los Angeles)
Hi Rick. Hope all is well

Eric- Atlanta
Seminar link and info: https://aspatients.org/event/transperineal-vs-transrectal-biopsy-2025/

Eric- Atlanta
“Key Clinical Trials Driving the Debate Recent trials have brought new insights: Dr. Jim Hu (PREVENT, 2024): Zero infections with TP vs 1.4% with TR, suggesting a reduced risk of sepsis. Dr. Alastair Lamb and Dr. Richard Bryant (TRANSLATE, 2025): TP detected 5–6% more clinically significant cancers (Grade Group ≥ 2) and often required no antibiotics. Dr. Badar Mian (PRoBE-PC, 2024): Both methods proved safe and effective, giving patients more choice. Together, these studies have reshaped how experts think about prostate biopsy safety.”

Ray E Santa Monica Ca
https://www.perplexity.ai/search/262e8d77-95e5-4fef-aa07-9b7a313c25f1

Ray E Santa Monica Ca
Above is a run down on TP vs Transrectal biopsy

Bill (VA)
Walter Reed now performing TP

AnCan – rick
AnCan Prostate Cancer Debate Aug 2022 Dr. George vs Dr. Kaye https://ancan.org/webinar-prostate-cancer-biopsies-the-great-debate/

Bill Harris (Los Angeles)
Bill Harris wmharris@gmail.com

Bill Harris (Los Angeles)
(new inherited mutation group

Active Surveillance Prostate Cancer Video Chat, January 28th, 2026

Active Surveillance Prostate Cancer Video Chat, November 12th, 2025

Active Surveillance Prostate Cancer Video Chat, November 12th, 2025

 

 

AnCan is grateful to the following sponsors for making this recording possible: Bayer, Novartis, Johnson and Johnson, Myriad Genetics, Telix, and Blue Earth Diagnostics.

Active Surveillance (AS) for low-risk prostate cancer involves unique challenges compared to other treatments. This online support group is designed for men and their caregivers who are currently on or considering AS. We hold four meetings monthly, recording only the second and fourth sessions. Our discussions cover a wide range of topics, including anxiety management, biopsy experiences, and the decision-making process around continuing or discontinuing AS. Newcomers are given priority to share their experiences, so we encourage you to join us.

You can find out more about our 12 monthly prostate cancer meetings at https://ancan.org/prostate-cancer/. Sign up to receive a weekly Reminder/Newsletter for this Group or others at https://ancan.org/contact-us/.

 

Chat Log:

AnCan – rick
If you have any technical problems, call GoTo at 877 582 7011

AnCan – rick
Dr. Jonathan Epstein – https://advanceduropathology.com Tel: 516-760-2037 jepstein@imppllc.com

AnCan – rick
Dr. Ming Zhou Mount Sinai Health System Department of Pathology, Box 1194 Annenberg Bldg. 15th FL 1468 Madison Ave New York, NY 10029 Email: Ming.zhou@mountsinai.org Telephone: (212)241-8881

Bill (VA)
You can be a “6” but that assumes it is all found.

AnCan – rick
Dr. Kristen Scarpato Vanderbilt https://www.vumc.org/urology/person/kristen-scarpato-md-mph

Dan Gifford, Pensacola, FL
Tapping out for the night. See you next week.

AnCan – rick
My bet is that Carroll would not recommend annual Bx for 3+3.

Phil-Toronto
agreed it has to be due pattern4

AnCan – rick
Absolutely agree with Michael